A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21788033

Download in:

View as

General Info

PMID
21788033